JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5651
First Trust Financials AlphaDEX Fund
FXO
$1.04B
| $26K | ﹤0.01% |
695
| – | – |
2022 Q3
2 quarters
|
|
5652
Goldman Sachs Access Investment Grade Corporate Bond ETF
GIGB
$954M
| $26K | ﹤0.01% |
+574
| New | +$26K |
2023 Q1
0 quarters
|
|
5653
CALL
HCA Healthcare
HCA
$94.2B
| $26K | ﹤0.01% |
100
-10,100
| -99% | -$2.57M |
2021 Q2
7 quarters
|
|
5654
Nuveen Mortgage and Income Fund
JLS
$88.7M
| $26K | ﹤0.01% |
+1,605
| New | +$26.5K |
2023 Q1
0 quarters
|
|
5655
PUT
Southwest Airlines
LUV
$20.5B
| $26K | ﹤0.01% |
800
-84,900
| -99% | -$2.89M |
2022 Q3
2 quarters
|
|
5656
Nuveen ESG Large-Cap Growth ETF
NULG
$3.1B
| $26K | ﹤0.01% |
462
-13
| -3% | -$687 |
2021 Q4
5 quarters
|
|
|
RPHS
5657
DELISTED
Regents Park Hedged Market Strategy ETF
RPHS
| $26K | ﹤0.01% |
+3,033
| New | +$25.5K |
2023 Q1
0 quarters
|
|
|
NSLR
5658
Neostellar Capital Corp
NSLR
$199M
| $26K | ﹤0.01% |
7,079
+1,838
| +35% | +$7.07K |
2022 Q3
2 quarters
|
|
5659
TH International
THCH
$39.1M
| $26K | ﹤0.01% |
+1,286
| New | +$25.9K |
2023 Q1
0 quarters
|
|
|
HLGN
5660
DELISTED
Heliogen, Inc.
HLGN
| $26K | ﹤0.01% |
3,084
+290
| +10% | +$4.4K |
2022 Q1
4 quarters
|
|
5661
Invesco S&P 500 BuyWrite ETF
PBP
$391M
| $25.9K | ﹤0.01% |
+1,224
| New | +$25.5K |
2023 Q1
0 quarters
|
|
5662
First Trust Multi Cap Value AlphaDEX Fund
FAB
$155M
| $25.9K | ﹤0.01% |
+372
| New | +$27K |
2023 Q1
0 quarters
|
|
5663
Fidus Investment
FDUS
$761M
| $25.9K | ﹤0.01% |
1,350
-1,000
| -43% | -$19.9K |
2018 Q1
20 quarters
|
|
5664
State Street SPDR S&P China ETF
GXC
$454M
| $25.4K | ﹤0.01% |
304
-110
| -27% | -$9.23K |
2019 Q4
13 quarters
|
|
5665
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$431M
| $25.1K | ﹤0.01% |
253
+111
| +78% | +$11.2K |
2021 Q1
8 quarters
|
|
5666
AMCON Distributing
DIT
$66.1M
| $25K | ﹤0.01% |
225
-129
| -36% | -$14.7K |
2021 Q3
6 quarters
|
|
|
DMF
5667
DELISTED
BNY Mellon Municipal Income
DMF
| $25K | ﹤0.01% |
+3,888
| New | +$24.9K |
2023 Q1
0 quarters
|
|
5668
AEye
LIDR
$51.3M
| $25K | ﹤0.01% |
2,611
-361
| -12% | -$6.23K |
2021 Q3
6 quarters
|
|
5669
Momentus
MNTS
$78.6M
| $25K | ﹤0.01% |
3
| – | – |
2021 Q4
5 quarters
|
|
5670
CALL
ON Semiconductor
ON
$33.5B
| $25K | ﹤0.01% |
+300
| New | +$22.8K |
2023 Q1
0 quarters
|
|
|
5671
PUT
ON Semiconductor
ON
$33.5B
| $25K | ﹤0.01% |
300
-162,600
| -100% | -$12.4M |
2022 Q4
1 quarter
|
|
5672
ProMIS Neurosciences
PMN
$84M
| $25K | ﹤0.01% |
208
-12
| -5% | -$1.47K |
2022 Q3
2 quarters
|
|
|
RIV
5673
RiverNorth Opportunities Fund
RIV
$320M
| $25K | ﹤0.01% |
+2,178
| New | +$25.8K |
2023 Q1
0 quarters
|
|
|
SY
5674
So-Young International
SY
$276M
| $25K | ﹤0.01% |
11,581
-26,816
| -70% | -$62.1K |
2020 Q1
12 quarters
|
|
|
TUYA
5675
Tuya Inc
TUYA
$1.03B
| $25K | ﹤0.01% |
13,372
+1,782
| +15% | +$4.02K |
2022 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.